Showing 6771-6780 of 8583 results for "".
- UCB’s Bimekizumab Performs Well in Phase 3 Psoriasis Studyhttps://practicaldermatology.com/news/ucbs-bimekizumab-performs-well-in-phase-3-psoriasis-study/2460186/UCB’s bimekizumab, an IL-17A and IL-17F inhibitor, bested placebo and Stelara (ustekinumab) when it came to clearing the skin of patients with moderate-to-severe chronic plaque psoriasis and improving their symptoms, the company reports. BE VIVID is the first of three Phase 3
- Psoriasis Linked to Developing and Dying from Cancerhttps://practicaldermatology.com/news/psoriasis-linked-to-developing-and-dying-from-cancer/2460185/Psoriasis may increase the risk for certain cancers, according to a review of 58 studies published in JAMA Dermatology. Moreover, the risk of dying from certain site-specific cancers was elevated in those with severe psoriasis. Specifically, severe psoriasi
- Botox Hits the Big 3-0https://practicaldermatology.com/news/botox-hits-the-big-3-0/2460184/Botox is turning 30, and Allergan fêted its shining star, Botox Cosmetic, in style at a New York City bash. The event included the debut of Botox Cosmetic’s new packaging and a panel discussion featuring New York City dermatologists Macrene Alexiades-Armenakas, MD, PhD
- Obagi Program at ASDS to Focus on Inclusionhttps://practicaldermatology.com/news/obagi-program-at-asds-to-focus-on-inclusion/2460183/Obagi and actor, producer and activist, Priyanka Chopra Jonas, will lead a panel of top dermatologists in a discussion about the importance of diversity and inclusion in medical aesthetics during the annual meeting of the American Society for Dermatologic Surgery (ASDS) in Chicago next week. 
- Allergan Shareholders Approve Proposed Acquisition by AbbViehttps://practicaldermatology.com/news/allergan-shareholders-approve-proposed-acquisition-by-abbvie/2460181/Allergan’s shareholders approved the previously announced proposed acquisition of Allergan by AbbVie Inc. More than 99 percent of the votes cast at both a special court-ordered meeting of shareholders and at an extraordinary general meeting of shareholders were in favor of the tra
- Positive Top-line Results Seen in Pivotal Phase 3 Clinical Trial of StrataGraft Regenerative Tissue Deep Partial-thickness Thermal Burnshttps://practicaldermatology.com/news/positive-top-line-results-seen-in-pivotal-phase-3-clinical-trial-of-stratagraft-regenerative-tissue-deep-partial-thickness-thermal-burns/2460178/Mallinckrodt plc's pivotal Phase 3 clinical trial evaluating the efficacy and safety of a single application of StrataGraft regenerative tissue in the treatment of deep partial-thickness thermal burns met both primary endpoints. The pivotal open-label, controlled, randomized, multic
- EADV News: Psoriasis Largely Undertreated, Travels with Anxietyhttps://practicaldermatology.com/news/eadv-news-psoriasis-largely-undertreated-travels-with-anxiety/2460175/Many psoriasis patients remain un- or undertreated, with an average diagnosis time of five years, according to research presented at the 28th European Dermato-Venereology Society Congress in Madrid. In the study of 650 psoriasis patients in Germany, more than half of patients (56 percen
- Research Substantiates Psoriasis/Non-alcoholic Fatty Liver Disease Linkhttps://practicaldermatology.com/news/research-substantiates-psoriasisnon-alcoholic-fatty-liver-disease-link/2460174/The severity of psoriasis is related to the severity of non-alcoholic fatty liver disease (NAFLD), according to research presented at the 28th European Dermato-Venereology Society Congress in Madrid. Patients with psoriasis and NAFLD had more severe hepatic damage if they had a higher s
- Pediatric AD Takes Its Toll on Caregiver Emotional Wellbeinghttps://practicaldermatology.com/news/ad-takes-its-toll-on-caregiver-emotional-wellbeing/2460173/Family members and caregivers of children with atopic dermatitis (AD) may be at increased risk for anxiety and depression, according to new research presented at the 28th European Dermato-Venereology Society Congress in Madrid. Researchers from the PHIUniversity Clinic of Dermatol
- EADV News: Diet Linked to Acnehttps://practicaldermatology.com/news/eadv-news-diet-linked-to-acne/2460172/Consuming dairy products, sweets, soda or juice daily may increase risk for developing acne, according to research presented at the 28th European Dermato-Venereology Society Congress in Madrid. The study, which included of more than 6,700 participants across six countries in North